Szatmári, Szabolcs
Szász, József Attila
Orbán-Kis, Károly
Bataga, Simona
Ciorba, Marius
Nagy, Előd
Neagoe, Radu
Mihály, István
Szász, Péter Zsombor
Kelemen, Krisztina
Frigy, Attila
Csipor-Fodor, Andrea
Constantin, Viorelia Adelina
Article History
Received: 9 October 2023
Accepted: 11 February 2024
First Online: 14 February 2024
Competing interests
: Szabolcs Szatmári: consultant and speaking honoraria: Boehringer-Ingelheim, Sanofi. József Attila Szász: consultant and speaking honoraria: Abbvie, Boehringer-Ingelheim, GSK, Lundbeck, Novartis, Pfizer, Stada, Teva, UCB. Károly Orbán-Kis: speaking honoraria: Richter, Zentiva, Berlin-Chemie, Pfizer, KRKA. Viorelia Adelina Constantin: speaking honoraria: Abbvie, Bayer, UCB, Wörwag Pharma. Ligia Ariana Bancu: speaking honoraria: Abbvie, Alfasigma, Sanofi. Marius Ciorba: speaking honoraria Abbvie. Alfasigma, Krka, Naturpharma, SunWave, Terapia All the remaining authors have no competing interest.